Newbridge Financial Services Group, Inc. - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 35 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$3,0000.0%1,2690.0%0.00%
+100.0%
Q1 2022$3,000
-50.0%
1,269
-16.0%
0.00%
-66.7%
Q4 2021$6,0000.0%1,5100.0%0.00%
-25.0%
Q3 2021$6,000
+200.0%
1,510
+194.3%
0.00%
+300.0%
Q2 2021$2,000
-60.0%
5130.0%0.00%
-75.0%
Q1 2021$5,000
+25.0%
513
+20.1%
0.00%
+33.3%
Q4 2020$4,000
+100.0%
4270.0%0.00%
+50.0%
Q3 2020$2,0004270.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 275,000$1,103,0000.40%
Manatuck Hill Partners, LLC 273,100$1,095,0000.38%
Stonepine Capital Management, LLC 165,775$665,0000.30%
Ikarian Capital, LLC 311,041$1,247,0000.09%
COOPERMAN LEON G 200,000$802,0000.04%
Jump Financial, LLC 18,300$73,0000.01%
Shay Capital LLC 10,000$40,0000.01%
Newbridge Financial Services Group, Inc. 1,510$6,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 30,904$124,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$5,0000.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders